BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17962299)

  • 21. Expression of a testis-specific form of Gal3st1 (CST), a gene essential for spermatogenesis, is regulated by the CTCF paralogous gene BORIS.
    Suzuki T; Kosaka-Suzuki N; Pack S; Shin DM; Yoon J; Abdullaev Z; Pugacheva E; Morse HC; Loukinov D; Lobanenkov V
    Mol Cell Biol; 2010 May; 30(10):2473-84. PubMed ID: 20231363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region.
    Nguyen P; Cui H; Bisht KS; Sun L; Patel K; Lee RS; Kugoh H; Oshimura M; Feinberg AP; Gius D
    Cancer Res; 2008 Jul; 68(14):5546-51. PubMed ID: 18632606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cell cycle role for the epigenetic factor CTCF-L/BORIS.
    Rosa-Garrido M; Ceballos L; Alonso-Lecue P; Abraira C; Delgado MD; Gandarillas A
    PLoS One; 2012; 7(6):e39371. PubMed ID: 22724006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Widespread expression of BORIS/CTCFL in normal and cancer cells.
    Jones TA; Ogunkolade BW; Szary J; Aarum J; Mumin MA; Patel S; Pieri CA; Sheer D
    PLoS One; 2011; 6(7):e22399. PubMed ID: 21811597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Common Polymorphism within the IGF2 Imprinting Control Region Is Associated with Parent of Origin Specific Effects in Infantile Hemangiomas.
    Schultz B; Yao X; Deng Y; Waner M; Spock C; Tom L; Persing J; Narayan D
    PLoS One; 2015; 10(10):e0113168. PubMed ID: 26496499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BORIS/CTCFL mRNA isoform expression and epigenetic regulation in epithelial ovarian cancer.
    Link PA; Zhang W; Odunsi K; Karpf AR
    Cancer Immun; 2013; 13():6. PubMed ID: 23390377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MAGEA1 inhibits the expression of BORIS via increased promoter methylation.
    Zhao J; Wang Y; Liang Q; Xu Y; Sang J
    J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30498011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation of the human retinoblastoma tumor suppressor gene promoter by CTCF.
    De La Rosa-Velázquez IA; Rincón-Arano H; Benítez-Bribiesca L; Recillas-Targa F
    Cancer Res; 2007 Mar; 67(6):2577-85. PubMed ID: 17363576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells.
    Kang Y; Hong JA; Chen GA; Nguyen DM; Schrump DS
    Oncogene; 2007 Jun; 26(30):4394-403. PubMed ID: 17260018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein.
    Schwarzenbach H; Eichelser C; Steinbach B; Tadewaldt J; Pantel K; Lobanenkov V; Loukinov D
    BMC Cancer; 2014 Nov; 14():796. PubMed ID: 25363021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours.
    D'Arcy V; Pore N; Docquier F; Abdullaev ZK; Chernukhin I; Kita GX; Rai S; Smart M; Farrar D; Pack S; Lobanenkov V; Klenova E
    Br J Cancer; 2008 Feb; 98(3):571-9. PubMed ID: 18195709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
    Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
    Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CTCF and BORIS in genome regulation and cancer.
    Marshall AD; Bailey CG; Rasko JE
    Curr Opin Genet Dev; 2014 Feb; 24():8-15. PubMed ID: 24657531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The combined action of CTCF and its testis-specific paralog BORIS is essential for spermatogenesis.
    Rivero-Hinojosa S; Pugacheva EM; Kang S; Méndez-Catalá CF; Kovalchuk AL; Strunnikov AV; Loukinov D; Lee JT; Lobanenkov VV
    Nat Commun; 2021 Jun; 12(1):3846. PubMed ID: 34158481
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Hillman JC; Pugacheva EM; Barger CJ; Sribenja S; Rosario S; Albahrani M; Truskinovsky AM; Stablewski A; Liu S; Loukinov DI; Zentner GE; Lobanenkov VV; Karpf AR; Higgins MJ
    Mol Cancer Res; 2019 Oct; 17(10):2051-2062. PubMed ID: 31292201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BORIS in human cancers -- a review.
    Martin-Kleiner I
    Eur J Cancer; 2012 Apr; 48(6):929-35. PubMed ID: 22019212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory factor interactions and somatic silencing of the germ cell-specific ALF gene.
    Kim M; Li D; Cui Y; Mueller K; Chears WC; DeJong J
    J Biol Chem; 2006 Nov; 281(45):34288-98. PubMed ID: 16966320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative usages of multiple promoters of the acetyl-CoA carboxylase beta gene are related to differential transcriptional regulation in human and rodent tissues.
    Oh SY; Lee MY; Kim JM; Yoon S; Shin S; Park YN; Ahn YH; Kim KS
    J Biol Chem; 2005 Feb; 280(7):5909-16. PubMed ID: 15590647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imprinting regulation of the murine Meg1/Grb10 and human GRB10 genes; roles of brain-specific promoters and mouse-specific CTCF-binding sites.
    Hikichi T; Kohda T; Kaneko-Ishino T; Ishino F
    Nucleic Acids Res; 2003 Mar; 31(5):1398-406. PubMed ID: 12595547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer.
    Fiorentino FP; Macaluso M; Miranda F; Montanari M; Russo A; Bagella L; Giordano A
    Mol Cancer Res; 2011 Feb; 9(2):225-33. PubMed ID: 21325284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.